Collectively, our xenograft experiment results suggest that RUNX3 expression in CAFs could contribute to the promotion of tumor growth, at least, through stimulating the tumor cell proliferation and blood vessel formation in human breast cancer. Here, RUNX3 is linked to breast carcinoma.